Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
1.520
+0.040 (2.70%)
At close: Aug 29, 2025, 4:00 PM
1.490
-0.030 (-1.97%)
After-hours: Aug 29, 2025, 4:14 PM EDT

Camp4 Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
39.0564.0438.3883.19
Cash & Short-Term Investments
39.0564.0438.3883.19
Cash Growth
209.76%66.86%-53.86%-
Other Receivables
0.110.110.440.68
Receivables
0.110.110.440.68
Prepaid Expenses
0.650.930.360.16
Other Current Assets
1.281.310.830.38
Total Current Assets
41.0966.3840.0184.41
Property, Plant & Equipment
8.5710.313.3116.79
Other Long-Term Assets
1.621.621.621.35
Total Assets
51.2878.3154.95102.55
Accounts Payable
1.21.211.042.15
Accrued Expenses
2.874.33.013.17
Current Portion of Long-Term Debt
0.10.090.41-
Current Portion of Leases
3.173.093.062.37
Current Unearned Revenue
-0.39--
Other Current Liabilities
-0.540.290.26
Total Current Liabilities
7.349.67.817.95
Long-Term Debt
--0.09-
Long-Term Leases
3.955.568.6410.03
Other Long-Term Liabilities
000-0.04
Total Liabilities
11.2915.1616.5317.93
Common Stock
0000
Additional Paid-In Capital
276.76274.936.2333.14
Retained Earnings
-236.77-211.75-159.96-110.67
Total Common Equity
39.9963.14-123.73-77.53
Shareholders' Equity
39.9963.1438.4284.62
Total Liabilities & Equity
51.2878.3154.95102.55
Total Debt
7.228.7312.1812.4
Net Cash (Debt)
31.8355.3126.270.8
Net Cash Growth
1423.74%111.12%-63.00%-
Net Cash Per Share
2.1911.7966.33226.69
Filing Date Shares Outstanding
20.1620.150.460.31
Total Common Shares Outstanding
20.1620.150.460.31
Working Capital
33.7556.7932.2176.46
Book Value Per Share
1.983.13-268.57-248.26
Tangible Book Value
39.9963.14-123.73-77.53
Tangible Book Value Per Share
1.983.13-268.57-248.26
Machinery
6.135.574.784.17
Leasehold Improvements
4.524.524.524.52
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q